Kymera Investor Presentation Deck
# of Patients by HS-PGA Score
12
10
00
2
O
2
1
9
HS-PGA Score Over Time (N=12*)
Baseline
2
1
6
2
Physician's Global Assessment (HS-PGA)
1
Day 14
■Clear ■Minimal ■Mild
2
1
5
3
1
1
1
4
3
KYMERA ©2023 KYMERA THERAPEUTICS, INC.
1
1
Day 28
Day 35
Moderate ■Severe ■Very Severe
1
1
4
1
Day 42
# of Patients by HS-PGA Score
OHN W AUT a 5
*One patient is censored for Day 35 and Day 42 since the patient started on ustekinumab, steroids and abx on Day 34.
10
HS-PGA Score Over Time Moderate to
Severe Patients (N=10)
1
9
Baseline
Clear
HS-PGA scores remained stable or improved in all patients
Disease cleared in 1 patient with moderate disease at baseline
1
6
2
1
Day 14
Minimal
1
5
3
1
Day 28
1
4
3
1
1
Day 35
Mild Moderate ■Severe
1
4
1
Day 42
PAGE 27View entire presentation